Technological Advances to Boost the Carotid Stents Market | Technavio
Technavio’s latest market research report on the global carotid stents marketprovides an analysis of the most important trends expected to impact the market outlook from 2017-2021. Technaviodefines an emerging trend as a factor that has the potential to significantly impact the market and contribute to its growth or decline.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171023006226/en/
Technavio has published a new report on the global carotid stents market from 2017-2021. (Graphic: Business Wire)
The global carotid stents market is expected to grow at a CAGR of more than 12%. The market is witnessing considerable growth owing to technological advances and the rising demand for MI procedures. In addition, focus on partnerships and acquisitions by major companies is also expected to contribute to the growth of the market.
According to Neha Noopur, a lead analyst at Technavio for cardiovascular devices research, “The carotid stents market is estimated to grow at a significant pace as consumers in developed markets such as Europe, Japan, and the US are emphasizing on availing quality and technologically advanced products. Meanwhile, the rising standard of living in emerging markets is also leading to an increase in the demand for these products.”
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
The top three emerging market trends driving the global carotid stents market according to Technavio research analysts are:
- Increase in M&A
- Continuous technological advances
- Rising demand for MI procedures
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Increase in M&A
Companies are adopting M&A to expand their presence globally. They are also using this strategy to increase their product portfolio and market share. This strategy empowers organizations to juxtapose innovation with R&D abilities. The trade increases the opportunities for small organizations, as the larger organizations are constantly interested in acquiring them for their development prospects.
“M&As remain an important option for various medical device manufacturing companies. Organizations keep looking out for suitable prospects which exhibit long-term growth prospects. Such acquisitions help organizations to expand their product portfolio and diversify in the medical devices and diagnostics market,” says Neha.
Continuous technological advances
For a considerable period, stents have been used as a part of coronary and peripheral procedures in Europe and the US to avoid or neutralize the narrowing and hindering of vessels. While the utilization of stents has been effective, they are not without downsides and concerns. Restenosis, or the reoccurrence of vessel narrowing after an interventional procedure, is a typical symptom arising due to a body's normal reaction to a foreign particle in the vasculature.
Drug-eluting stents (DES) result in better clinical outcomes by reducing the risk of restenosis significantly. New improvements in DES such as biodegradable and bifurcated stents are required to increase the market value of a company. Organizations like Biosensors and Abbott are creating biodegradable and bifurcated stents to manage issues pertaining to thrombosis, which is caused by long-term device implantation.
Rising demand for MI procedures
The demand for MI procedures has been increasing globally. MI procedures relatively reduce the physical injury risk and the chances of an infection, thereby enabling patients to have a more convenient and quicker recovery. MI procedures have certain advantages such as affordable cost and shorter hospital stay. These methods have shown better outcomes than traditional methods. However, the cost of an MI procedure can be higher when compared with the other traditional methods, which may be a limiting factor in developing countries.
MI procedures for heart diseases involve the insertion of delicate instruments through a small incision. Patients treated with these technologies can expect lesser discomfort and scarring and quicker recuperation, as compared to conventional surgeries. MI procedures have helped in the effective management of a few infections. These have also allowed specialists to make substantially smaller incisions.
Browse Related Reports:
- Global Cardiac Rhythm Management (CRM) Devices Market 2017-2021
- Global Cardiac Biomarkers Market 2017-2021
- Global Vascular Grafts Market 2017-2021
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171023006226/en/
Technavio Research
Jesse Maida
Media & Marketing Executive
US:
+1 844 364 1100
UK: +44 203 893 3200
www.technavio.com
